The Japan dermatological market size stood at around USD 6.7 million in 2020 and is projected to reach USD XX million by 2028, exhibiting a CAGR of xx% during the forecast period.
With the rise in the ageing population in Japan, dermatological care is likely to receive particular attention. As people age, the risk of developing skin-related disorders increases, due to factors, such as changes in the connective tissue, reduction in the skin’s strength and elasticity, and reduction in secretions from sebaceous glands. Skin conditions pose a significant threat to patient’s well-being, mental health, ability to function, and social participation.
The increasing incidence of dermatological diseases and increasing levels of awareness-related disease progression, etiology, and available therapies are leading to the high growth of dermatological therapeutics.
The Japanese Dermatological Association conducted a nationwide study and the information on 67,448 cases that participated was analyzed. The 20 most common diseases were miscellaneous eczema (18.67%) followed, in order, by atopic dermatitis (9.98%), tinea pedis (6.49%), urticaria ⁄angioedema (4.99%), tinea unguium (4.79%), viral warts (4.49%), psoriasis (4.43%), contact dermatitis (3.92%), acne (3.6%), seborrheic dermatitis (3.28%), hand eczema (3%), miscellaneous benign skin tumors (2.47%), alopecia areata (2.45%), herpes zoster ⁄ zoster-associated pain (2.39%), skin ulcers (non-diabetic) (1.98%), prurigo (1.82%), epidermal cysts (1.77%), vitiligo Vulgaris (1.68%), seborrheic keratosis (1.62%) and drug eruption ⁄ toxicoderma (1.51%).